Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 10/20 | 0.45 |
| ▸ | SLC9A2 | Q9UBY0 | 3/20 | 0.45 |
| ▸ | HTR2B | P41595 | 6/20 | 0.43 |
| ▸ | HTR7 | P34969 | 4/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30666294 | 0.82 | KDM4E (0.39) | — | |
| SCHEMBL9322018 | 0.79 | PDK2 (0.38) | — | |
| SCHEMBL17786098 | 0.77 | PTGDR2 (0.38) | CYP2D6 | |
| SCHEMBL29486091 | 0.77 | KDM4E (0.32) | — | |
| SCHEMBL27534925 | 0.74 | KDM4E (0.49) | CYP2D6 | |
| SCHEMBL29486064 | 0.73 | ALDH1A1 (0.50) | — | |
| SCHEMBL18029750 | 0.73 | SLC6A4 (0.42) | — | |
| SCHEMBL14625710 | 0.72 | G6PD (0.50) | CYP2C9 | |
| Hydrochloric Acid SCHEMBL8955937 | 0.72 | SLC9A1 (0.49) | SLC9A1SLC9A2HTR2BHTR7PLAU | |
| SCHEMBL27728938 | 0.72 | G6PD (0.50) | CYP2C9CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114423741-B | aryl-N-aryl derivatives for the treatment of RNA viral infections | ABIVAX公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-114423741-A | aryl-N-aryl derivatives for the treatment of RNA viral infections | ABIVAX公司 | 2022-04-29 | — | — | CN | disclosed |